Muskuloskeletal system diseases

For patients with musculoskeletal system diseases, the use of Pelodex is indicated in case of:

Consequences of injuries of the musculoskeletal system during the rehabilitation period. Contributes to the elimination of edema, trophic disorders,
Changes in sensitivity, etc. Activates the process of bone fracture healing;
Consequences of past rheumatic arthritis or polyarthritis;
Rheumatoid arthritis or polyarthritis in an inactive phase;
Ankylosing spondylitis in the phase of remission;
Reactive arthritis (after nasopharyngeal infection and other infections) in the chronic stage;
Microcrystalline arthritis (gouty arthritis or polyarthritis);
Primary osteoarthrosis (polyostearosis, oligoarthrosis, monoarthrosis, spondylosis, intervertebral osteochondrosis) and secondary (due to dysplasia, arthritis, injuries, static disorders, as well as hypermobility);
Arthropathy in case of non-rheumatic diseases (related to endocrine diseases – myxedematous, climacteric);
Osteochondropathy (Peters, Kinbeck, Koenig, Koehler 1 and 2, Sherman-Mau disease);
Soft tissue diseases (myositis, enteropathies, including epicondylitis, tendinitis, tendovaginitis, synovitis, bursitis, periarthritis, migamentitis, fasciitis, aponeurosis, including Dupuytren’s contracture);
Contractures: artogenic, osteogenic, cicatricial, neurogenic;
Chronic, hematogenous osteomyelitis (except tuberculous);
varicose veins, Tired legs disease.